Clicky

Aclaris Therapeutics, Inc.(ACRS) News

Date Title
Jun 30 Aclaris Therapeutics Added to the Russell 2000® and Russell 3000® Indexes
Jun 26 Aclaris Therapeutics to Participate in the H.C. Wainwright Inflammation & Immunology Virtual Conference
Jun 23 Aclaris Therapeutics Initiates Phase 1a/1b Program for its Novel Bispecific Antibody ATI-052
Jun 2 Aclaris Therapeutics Initiates Phase 2 Trial of Bosakitug (ATI-045) in Atopic Dermatitis
Feb 27 Aclaris Therapeutics (ACRS) Reports Q4 Loss, Tops Revenue Estimates
Feb 27 Aclaris: Q4 Earnings Snapshot
Feb 27 Aclaris Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides a Corporate Update
Feb 12 New Publication Highlights Unique Properties of ATI-2138, a Potent and Selective Inhibitor of ITK and JAK3
Jan 30 Aclaris Therapeutics Announces Formation of New Scientific Advisory Board
Nov 26 Aclaris Therapeutics to Participate in the Piper Sandler 36th Annual Healthcare Conference
Nov 22 Aclaris Therapeutics And 2 Other US Penny Stocks To Watch
Nov 6 Aclaris Therapeutics (ACRS) Reports Q3 Loss, Misses Revenue Estimates
Nov 6 Aclaris: Q3 Earnings Snapshot
Nov 6 Aclaris Therapeutics Reports Third Quarter 2024 Financial Results and Provides a Corporate Update
Oct 9 Millennium Management LLC Reduces Stake in Aclaris Therapeutics Inc
Oct 8 Is BellRing Brands (BRBR) Stock Outpacing Its Medical Peers This Year?
Jun 6 Aclaris Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
May 10 Earnings Update: Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Just Reported And Analysts Are Boosting Their Estimates
May 8 Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Q1 2024 Earnings Call Transcript
May 8 Q1 2024 Aclaris Therapeutics Inc Earnings Call